By Michael Solomon, PhD, MBA Big moves by market-leading commercial payers signal sweeping transformative change is underway for health insurers and pharmacy benefit managers (PBMs). This change has the potential …
By Tony Schueth Addressing medication noncompliance is one of the trends we will be seeing in 2018. To be sure, medication noncompliance is a long-standing issue. We have known for …
By Michael Burger, Senior Consultant I read with interest Joel White’s Op-Ed piece entitled Leverage the Power of Health IT to Stem the Tide of Opioid Abuse. One statement stood …
By Connie Sinclair, Director, Regulatory Resource Center Lawmakers are reacting to America’s opioid epidemic by creating new mandates that will affect electronic health records (EHRs). Compliance will create many challenges …
By Michael Burger and Chuck Frederick, Senior Consultants Vendors of electronic health records (EHRs) should be doing a happy dance over the recent announcement from the Office of the National …
By Connie Sinclair, Director, Regulatory Resource Center Until recently, Missouri was the only state without a Prescription Drug Monitoring Program (PDMP). Growing evidence suggests that use of these state-run databases …
By Michael Burger, Practice Lead, EHRs and EDI Electronic health records (EHRs) are taking a lot of heat these days. Lloyd Minor, M.D., the dean of Stanford University’s School …
By Pooja Babbrah, Senior Consultant Stakeholders across the industry are debating potential costs and burden associated with implementing the new, nonproprietary naming convention for biologics and biosimilars. Requirements for the …
By Michael Burger, Senior Consultant Providers need tools for population health management (PHM) for reimbursement as well as reporting on metrics for related activities and quality improvement. While most physicians …
By Pooja Babbrah, Senior Consultant Getting patients to adhere to their medication regimen is a growing problem—and solutions are being sought. The reasons are compelling. Non-adherence to prescribed medications results in $100 to $300 billion in avoidable healthcare costs. A significant portion of …